Eva Zusinaite
Overview
Explore the profile of Eva Zusinaite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
968
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu X, Ng W, Zusinaite E, Freitas J, Taylor A, Yerragunta V, et al.
Nat Commun
. 2024 Aug;
15(1):7225.
PMID: 39187479
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) continues its significant health and economic impact globally. Despite the success of spike-protein vaccines in preventing severe disease, long-lasting protection against emerging...
2.
Ianevski A, Froysa I, Lysvand H, Calitz C, Smura T, Nilsen H, et al.
Antiviral Res
. 2024 Feb;
224:105842.
PMID: 38417531
Enteroviruses are a significant global health concern, causing a spectrum of diseases from the common cold to more severe conditions like hand-foot-and-mouth disease, meningitis, myocarditis, pancreatitis, and poliomyelitis. Current treatment...
3.
Ravlo E, Ianevski A, Starheim E, Wang W, Ji P, Lysvand H, et al.
Int J Infect Dis
. 2023 Oct;
137:75-78.
PMID: 37852599
Vaccinated convalescents do not develop severe COVID-19 after infection with new SARS-CoV-2 variants. We questioned how messenger RNA (mRNA) vaccination of convalescents provides protection from emerging virus variants. From the...
4.
Nefedova A, Rausalu K, Zusinaite E, Kisand V, Kook M, Smits K, et al.
Heliyon
. 2023 Oct;
9(9):e20067.
PMID: 37810009
Due to the growing interest towards reducing the number of potentially infectious agents on critical high-touch surfaces, the popularity of antimicrobially and antivirally active surfaces, including textiles, has increased. The...
5.
Hermet P, Delache B, Herate C, Wolf E, Kivi G, Juronen E, et al.
PLoS Pathog
. 2023 Aug;
19(8):e1011532.
PMID: 37531329
The COVID-19 pandemic represents a global challenge that has impacted and is expected to continue to impact the lives and health of people across the world for the foreseeable future....
6.
Kubo A, Rausalu K, Savest N, Zusinaite E, Vasiliev G, Viirsalu M, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559043
Due to the high prevalence of infectious diseases and their concurrent outbreaks, there is a high interest in developing novel materials with antimicrobial properties. Antibacterial and antiviral properties of a...
7.
Ianevski A, Ahmad S, Anunnitipat K, Oksenych V, Zusinaite E, Tenson T, et al.
Cell Mol Life Sci
. 2022 Nov;
79(12):605.
PMID: 36436108
The viral epidemics and pandemics have stimulated the development of known and the discovery of novel antiviral agents. About a hundred mono- and combination antiviral drugs have been already approved,...
8.
Nefedova A, Rausalu K, Zusinaite E, Vanetsev A, Rosenberg M, Koppel K, et al.
Sci Rep
. 2022 Nov;
12(1):18746.
PMID: 36335167
Nanomaterials are prospective candidates for the elimination of viruses due to their multimodal mechanisms of action. Here, we tested the antiviral potential of a largely unexplored nanoparticle of cerium dioxide...
9.
Ianevski A, Zusinaite E, Tenson T, Oksenych V, Wang W, Afset J, et al.
Viruses
. 2022 Sep;
14(9).
PMID: 36146673
Enterovirus infections affect people around the world, causing a range of illnesses, from mild fevers to severe, potentially fatal conditions. There are no approved treatments for enterovirus infections. We have...
10.
Naaber P, Tserel L, Kangro K, Punapart M, Sepp E, Jurjenson V, et al.
Cell Rep Med
. 2022 Aug;
3(8):100716.
PMID: 35952669
The high number of mutations in the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes its immune escape. We report a longitudinal analysis of 111 vaccinated individuals...